Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/25/25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
|
  |
101 |
| 08/15/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
 |
97 |
| 09/14/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
124 |
| 08/15/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
202 |
| 07/30/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
203 |
| 08/14/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
308 |
| 08/14/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
147 |
| 07/27/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
103 |
| 07/20/17 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
129 |
| 07/19/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
68 |
